| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.6 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.031 | 0.6 |
| mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.6 |